Alan Gray, Author at World Asthma Foundation

Monoclonal Antibodies Anaphylaxis Risk For Severe Asthma Patients

Most monoclonal antibodies increase the risk of anaphylaxis in severe asthma patients, according to a report published in Clinical and Translational Allergy. The study found 4 out of 5 common mAbs were associated with an increased risk of anaphylaxis. Each…

By Alan Gray | July 22, 2021 | Severe Asthma |

New Treatment for Asthma? Airway Collagen Affects Breathing

A new study finds that manipulating the stiffness of the collagen in the airway has an effect on breathing. The airway consists of both a conducting region (larynx, trachea, bronchi, bronchioles) where air is humidified, warmed, and cleaned and a…

By Alan Gray | July 16, 2021 | Asthma News |

Asthma and Sustainable Healthcare – Rodney Dietert PhD Interview

World Asthma Foundation “Defeating Asthma Series Uncovers New Hope for Asthma Management Asthmatics: Our understanding of Asthma and the way we treat it may soon be radically different from what currently exists, due to new research on the human microbiome…

By Alan Gray | January 14, 2021 | Asthma and the Microbiome, Defeating Asthma Series, Featured Stories and Interviews |

Can we replace missing microbes? – Rodney Dietert Ph.D.

Defeating Asthma Series uncovers New Hope for Asthma Managementant In this fourth in a series of interviews with Rodney Dietert, PhD Cornell University Professor Emeritus, Health Scientist Head of Translational Science + Education for SEED and the Author of the…

By Alan Gray | October 8, 2020 | Asthma and the Microbiome, Asthma News, Defeating Asthma Series, Featured Stories and Interviews |